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Objectives: Pain in the orofacial region is frequently reported by patients in dental and
medical offices. Facial pain, headache, masticatory abnormalities and other complaints
often become chronic and may be associated with local disturbances, such as xerostomia
and teeth abnormalities. The objective of this study was to investigate salivary flow and
xerostomia in patients with orofacial pain.
Design: This was a case-control study; we evaluated 82 patients with chronic orofacial pain
compared with 56 healthy subjects using a Clinical Pain Questionnaire (pain characteristics,
duration, intensity and descriptors), complete dental examination (including static and
dynamic evaluation of the jaw) and a Xerostomia Inventory. The salivary flow was quanti-
tatively evaluated. Data was compared through Pearson’s chi-square, Fisher’s exact, analy-
sis of variance (ANOVA) 1 factor and Mann–Whitney tests.
Results: Patients often had temporomandibular disorder (TMD) (P = 0.001) and pain during
facial (P < 0.001) and neck palpation (P = 0.002). There were no differences in dental exami-
nation or other structural aspects of the jaw between the groups. There were more
complaints associated with xerostomia in the study group, including burning sensation
in the oral mucosa (P = 0.003), in the throat (P = 0.035) and in the stomach (P = 0.050). Patients
had lower salivary flow (P = 0.008).
Conclusions: Orofacial pain patients need to be evaluated with regard to their salivary
function, which was often found abnormal in this sample and may have contributed to
the complaints of these patients. Assessing salivary flow and xerostomia may help in the
treatment of chronic orofacial pain.
# 2011 Elsevier Ltd. 
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Open access under the Elsevier OA license.Saliva has an important role in the protection of the oral
tissues and the gastroenteric epithelium, and its absence or
alteration can cause many significant problems.1,2 Amongst
its functions, it facilitates the formation of the bolus,
swallowing, phonation and the retention of complete
dentures; it also prevents the damage of soft and hard tissues* Corresponding author. Tel.: +55 11 91842878.
E-mail address: silviadowgan@hotmail.com (Silvia R.D.T. de Sique
0003–9969  # 2011 Elsevier Ltd. 
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Open access under the Elsevier OA license.in the oral cavity by mechanical, chemical or biological
noxious stimuli.3 Saliva contains a variety of electrolytes,
peptides, glycoprotein, enzymes, immunoglobulin A,4 grow-
ing factors, amines5 and leucocytes,2 and amongst its
properties, the buffering effect prevents the demineralisation
of the teeth.6ira).
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can be evaluated by individual questionnaires, salivary tests
and sialometry, which can confirm the presence of lower
salivary flow or altered composition, associated or not with the
complaint.7,8 It can be caused by systemic diseases (e.g., Sjo¨gren
syndrome, diabetes and hypothyroidism),9–12 emotional stress,
abuse of drugs, human immunodeficiency virus (HIV) infec-
tion,13 radiation of the head and neck14 or chronic use of several
medications.15,16 The reduction of the salivary flow causes
many consequences that affect oral and the general health. The
most common complaints are discomfort and burning sensa-
tion,17 caused by the dryness of the oral mucosa and the
difficulty of feeding.18There are also taste loss, bad breath19and
difficulties in swallowing, talking20 and using prostheses.21Op-
portunist oral infections, such as candidiasis, or dental
problems (caries and periodontitis) may occur.22
Orofacial pain occurs at least once in a lifetime for 70% of
the people.23 Amongst the causes, dental pain and temporo-
mandibular disorders (TMDs) are the most frequent.24,25
Dental pain is often inflammatory and causes intense central
sensitisation.26 TMD includes articular and muscular diseases
involving the masticatory system.24Neuropathic pain syn-
dromes are also common in the face, and they may be
associated with TMD or odontalgia.27 There is a lack of studies
investigating salivary complaints in individuals with orofacial
pain; however, such abnormalities might contribute to the oral
discomfort of these patients. Thus, the objective of this study
was to investigate salivary flow and xerostomia in patients
with orofacial pain.
1. Materials and methods
1.1. Patients
We enrolled 112 consecutive patients with orofacial pain who
had been referred to the Neuropathic Facial Pain Clinic of the
Functional Neurosurgery Division, Psychiatry Institute, Hos-
pital das Clinicas, Medical School, University of Sao Paulo,
Brazil. They comprised all patients who were referred to
evaluation between May 2009 and April 2010. The criteria
included facial pain complaints for at least the last 6 months,
no diagnosis of generalised pain (e.g., rheumatoid arthritis and
fibromyalgia) and agreement to participate in the study. Thirty
patients were excluded because they did not fulfil the criteria;
82 were left. Patients were diagnosed according to the criteria
of the International Headache Society (2004).28 Thirty-two
patients had secondary diagnoses.
Fifty-six normal subjects were included in the control
group of this study; all of them had no history of facial or
generalised pain in the last 6 months. All patients and controls
were informed about the purposes of the study, and all signed
the informed consent. The protocol had been approved by the
local Ethics Committee. Demographic data were compared
using Pearson’s chi-square test (Statistical Package for Social
Sciences (SPSS) 17.0; SPSS Inc., IL, USA) and can be observed in
Table 2. There was a sex difference between the groups.
Twenty-seven (32.9%) patients and 13 (23.2%) controls were
accompanied by relatives, mostly spouses and sons/daugh-
ters; 64 patients (78.0%) and 29 controls (69.6%) were onchronic medication (P > 0.050). Amitriptyline was the most
common medication in the patient group (29; 35.3%), followed
by carbamazepine (22; 26.8%), anti-hypertensive drugs (13;
15.9%), common analgesics (four; 4.9%) and others (12; 14.6%).
Anti-hypertensive drugs were the most common medication
in the control group (30; 53.6%). There was a difference
between groups in relation to the use of antidepressants and
anti-hypertensive drugs (P < 0.001).
1.2. Instruments for orofacial evaluation
The questionnaires and exams were performed only by one
researcher, who ensured clear understanding of the content
by the participants before starting the protocol.
All subjects underwent a standardised protocol for the
evaluation of the orofacial region, including main complaint,
pain characteristics (location, quality, duration, descriptors,
intensity by the visual analogue scale – VAS, causal, alleviation
and aggravation factors), medical history and medications,
earache, headache, generalised body pain and sleep distur-
bances.29 All questions were open and included all answers
reported by the patient, validated for the diagnosis of orofacial
pains.29 Masticatory complaints, parafunctional habits and
laterality and quality of mastication were also investigated.
The diagnosis of TMD was based on symptoms and physical
exam following the criteria of the International Headache
Society.24
1.3. Dental exam
The dental exam included the static and dynamic evaluation
of the dentition as well as signs of oral habits. Missing teeth
replaced or not by dentures, decays and movement param-
eters of the jaw (interocclusal distances, protrusion and right
and left laterality) were observed. Pain from mandibular
movements, articular noises at the temporomandibular joints
(TMJs) and muscular palpation of the head and neck (bilateral
masseters, temporalis, digastrics, sternocleidomastoid, trape-
zius, splenius and suboccipitals) were also evaluated, as well
as the clinical aspects of the oral mucosa and tongue;
periodontal tissues were examined with periodontal probes
and classified according to the criteria of the American
Academy of Periodontology.30,31
1.4. Xerostomia and oral mucosa complaints
Oral complaints and xerostomia were assessed by the
Xerostomia Inventory validated to the Portuguese language.11
This questionnaire includes the investigation of dry-mouth
sensation, difficulties in oral functions due to loss of saliva,
halitosis, subjective sensation of dry skin, dry eyes or dry nose,
burning mouth, pharynx, stomach and intestine complaints
and, finally, the quality of digestion, through a ‘‘yes’’/‘‘no’’
question for each of the symptoms listed earlier.
1.5. Quantitative salivary evaluation
All patients were oriented to fast for 2 h before the exam, and
should not have smoked or chewed gum on the day of the
exam. Initially, two wads of cotton were placed in a plastic pot
a r c h i v e s o f o r a l b i o l o g y 5 6 ( 2 0 1 1 ) 1 1 4 2 – 1 1 4 71144(80 ml) and weighed on a precision scale (Acculab1 V1200).
After the patients had swallowed all saliva, the wads were
placed on the mouth floor, under the tongue, for 5 min. During
this period, the patient should not swallow. After that, the
cotton wads were removed and put back into the plastic pot for
weighing again. The difference between the values was
considered and divided by 5, so that the salivary flow was
obtained in g min1.32
1.6. Data analysis
Means, standard deviations and frequencies were computed
to summarise the distribution of values for each variable. After
the initial descriptive evaluation, variables were tested in
relation to the normal distribution with the Shapiro–Wilk test
and Q–Q plots. The use of medication and the period of the day
in which the evaluation was done (morning, afternoon or
evening) were considered in the analysis of salivary flow. Non-
parametric tests included Pearson’s chi-square, Fisher’s exact,
analysis of variance (ANOVA) 1 factor and Mann–Whitney
tests. The coefficient of Spearman was used for correlations.
The level of significance was 5%.
2. Results
The groups were different as regards gender distribution but
similar in ages, colour, marital status, occupation, height,
weight, co-morbidities, smoking habits and subjective smell
and taste complaints. There were more women in the study
group (79.3%) when compared with the control group (57.1%)
(P = 0.005).
2.1. Orofacial evaluation
There was a high intensity of pain by the VAS (8.01  2.72),
which was often daily and spontaneous (66–80.5%); the most
common pain descriptor was shock-like (34–41.5%); medica-
tion was the most common alleviation factor (33–40.2%); and
the pain usually had a spontaneous start (48–40.8%). The
mean duration of pain was 5.95  6.60 months (range from 0
to 30 months). The diagnoses of orofacial pain are outlined in
Table 1.Table 1 – Study group: orofacial pain diagnoses (N = 82).
N %
Primary diagnosis Trigeminal neuralgia 32 39.0
Burning mouth syndrome 14 17.1
Atypical facial pain 9 11.0
Temporomandibular disorder 8 9.8
Post-traumatic neuralgia 6 7.3
Post-herpetic neuralgia 6 7.3
Wallemberg syndrome 3 3.7
Facial palsy 3 3.7
Cervicogenic headache 1 1.1
Secondary diagnosis Temporomandibular disorder 28 34.1
Shwanoma/meningioma 2 2.4
Cervical myofascial pain 2 2.4In the study group, a higher frequency of TMD (P = 0.001),
worse quality of mastication (P < 0.001), higher frequency of
fatigue in the face (P = 0.047) and higher pain in mandibular
movements (P = 0.015), as well as in facial (P < 0.001) and neck
palpation (P = 0.002), were observed (Table 2). The groups did
not differ in parafunctional habits, complaints of pain whilst
awakening, articular noises and headache.
2.2. Dental exam
The dental exam (use of dental prosthesis, dental occlusion,
periodontal, teeth, tongue and mucosa characteristics) did not
show statistical differences between the groups; however,
mastication complaints were more frequent in the study
group (P = 0.002).
2.3. Salivary flow, xerostomia and associated variables
The differences with regard to xerostomia and associated
complaints can be observed in Table 3. The study group
presented more discomfort at the oral cavity, abnormal saliva,
dry-mouth sensation, difficulty of chewing due to xerostomia,
loss of taste due to xerostomia, change in the taste of food,
need of liquids to swallow, avoiding food due to xerostomia,
use of drinks other than water during the day, dry-eyes’
sensation, burning sensation at the mouth, sensation of
secretion at the throat, throat pain, avoiding the use of
dentures, difficulty in the use dentures at night due to
xerostomia and burning at stomach. There were no differ-
ences between the groups in relation to: difficulty in
swallowing saliva, difficulty in talking due to xerostomia,
dry-mouth sensation during meals, need for drinking water
during the night or chewing gum or eating sweets due to dry-
mouth sensation, number of glasses of water during the day,
abnormal taste, bad breath, sensation of dry vagina in women,
sensation of dry skin, sensation of dry nose, stuffy nose,
normal function of the intestines, quality of digestion or
difficulties with digestion. It was also observed that the
salivary flow in patients was lower when compared with the
controls (P = 0.008) (Fig. 1).
No correlations were observed amongst the variables. The
patients who used medications (antidepressants and/or anti-
hypertensive drugs) complained more about dry mouth
(P = 0.007); however, it was not associated with a reduced
salivary flow (P = 0.338). The doses of medications were not
investigated.
3. Discussion
This study showed that patients with orofacial pain had lower
salivary flow and more complaints of xerostomia than
controls. These complaints included abnormalities in masti-
cation, difficulties in wearing prostheses and discomfort and
pain in the oral mucosa and the gastroenteric tract. Saliva may
be playing a role in these findings as a consequence of or a co-
existing factor with chronic orofacial pain.
The high prevalence of dental prostheses and periodontal
infections in this sample corresponded to the expectation in
our population (Brazilian Health Ministry, 2003). However, the
Table 2 – Comparison of general and orofacial complaints between the study and control groups (N = 138).
Study group (N = 82) Control group (N = 56) P*
Quality of mastication Good 33 (40.2%) Good 47 (83.9%) <0.001
Bad 25 (30.5%) Bad 7 (12.5%)
Terrible 15 (18.3%) Terrible 2 (3.6%)
Painful 5 (6.1%) Painful 0 (0.0%)
Other 4 (4.9%) Other 0 (0.0%)
Fatigue at face Whilst chewing 7 (8.5%) Spontaneous 4 (7.1%) 0.047
In all jaw movements 7 (8.5%) When stressed 1 (1.8%)
Whilst awakening 6 (7.3%) Whilst awakening 1 (1.8%)
Whilst talking 5 (6.1%) Whilst talking 0 (0.0%)
Constant 3 (3.7%) Constant 0 (0.0%)
Pain in mandibular movements All movements 15 (18.3%) All movements 1 (1.8%) 0.015
Mouth opening 11 (13.4%) Mouth opening 1 (1.8%)
Laterality 3 (3.7%) Laterality 1 (1.8%)
TMDa 36 (43.9%) 2 (3.6%) 0.001
Pain at facial palpation All masticatory muscles 26 (31.7%) All masticatory muscles 0 (0.0%) <0.001
Masseter and temporalis 18 (22.0%) Masseter and temporalis 2 (3.6%)
Masseter 14 (17.1%) Masseter 12 (21.4%)
Neckache 32 (39.0%) 7 (12.5%) 0.002
Mastication complaints Pain 21 (25.6%) Pain 1 (1.8%) 0.002
Old dentures 5 (6.1%) Old dentures 3 (5.4%)
Absence of teeth 3 (3.7%) Absence of teeth 0 (0.0%)
Fatigue whilst chewing 5 (6.1%) Fatigue whilst chewing 1 (1.8%)
* Pearson’s chi-square; Fisher’s exact test.
a Temporomandibular disorder.
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theses (Table 3). This could be explained at least, in part, by the
reduced salivary flow observed in this study. Saliva plays a role
in the retention of dentures in the oral mucosa; it also protects
the oral tissues from the frequent injuries that they are
exposed to, and its absence can even impair digestion and
nutrition.1,2 It is important for the sensorial perception of
gustation, and, in fact, we observed an association between its
abnormalities and taste disturbances. Taste is a complex
sensory function that depends on the integration of several
sensorial modalities in central areas of the nervous system
involving gustation, olfaction, the temperature of food andTable 3 – Comparison of xerostomia and associated complain
Study gr
Discomfort at the oral cavity 60 
Abnormal saliva 30 
Dry mouth sensation 45 
Difficulty of chewing due to xerostomia 11 
Loss of taste due to xerostomia 24 
Change in the taste of food 16 
Need of liquids to swallow 17 
Avoiding food due to xerostomia 8 
Use of other drinks than water during the day 59 
Dry eyes sensation 32 
Burning sensation at the mouth 24 
Sensation of secretion at the throat 32 
Throat pain 18 
Avoiding the use of dentures 52 
Difficult to use dentures at night due to xerostomia 4 
Burning at stomach 30 
* Fisher’s exact test.tactile information, such as texture and consistence. Particu-
larly in the group of patients with neuropathic pain, especially
burning mouth syndrome (BMS), the altered somatosensory
transduction could contribute to the primary diagnosis of
BMS, which has been extensively discussed in the literature,33–
36 including by our group.37
Salivary flow was altered not only in the group of BMS, but
in all patients with orofacial pain evaluated in this study. The
reasons for this are not clear, and one hypothesis could be the
involvement of sensitised interneurons between pain path-
ways and the neurovegetative areas of the hypothalamus in
chronic pain processes. Tearing and increase of nasal mucusts between the study and control groups (N = 138).
oup (N = 82) Control group (N = 56) P*
(73.2%) 8 (14.3%) <0.001
(36.6%) 11 (19.6%) 0.024
(54.9%) 22 (39.3%) 0.050
(13.4%) 2 (3.6%) 0.045
(29.3%) 6 (10.7%) 0.007
(19.5%) 4 (7.1%) 0.034
(20.7%) 5 (8.9%) 0.050
(9.8%) 0 (0.0%) 0.013
(72.0%) 48 (85.7%) 0.043
(39.0%) 13 (23.2%) 0.038
(29.3%) 5 (8.9%) 0.003
(39.0%) 13 (23.2%) 0.038
(22.0%) 5 (8.9%) 0.035
(63.4%) 24 (42.9%) 0.014
(4.9%) 1 (1.8%) 0.034
(36.6%) 10 (17.9%) 0.050
Control GroupStudy Group
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*Mann-Whitney test
Fig. 1 – Comparison of salivary flow between the study and
control groups: interquartile range and medians (N = 138).
a r c h i v e s o f o r a l b i o l o g y 5 6 ( 2 0 1 1 ) 1 1 4 2 – 1 1 4 71146are often observed in chronic headaches.23 These findings
could also be associated with the use of chronic medications
that can interfere with salivary flow, especially antidepres-
sants, but, in this study, the use of these medications was not
associated with the reduction of saliva, but only with the dry-
mouth complaints. We did not evaluate the doses of these
medications. It is important to consider that patients with
higher doses of antidepressants could have lower salivary
flow, which could have interfered with our results, and
therefore needs further investigation. Other important factors
that were not evaluated and may interfere with saliva
production are anxiety and depression, which were not
investigated in this sample. These are often associated with
chronic-pain patients.
The characteristics of pain observed in this study corre-
sponded to the expected according to the diagnoses of the
patients; the most common diseases were neuropathic
(trigeminal neuralgia, BMS and atypical facial pain) and
corresponded to the nature of the clinic (neuropathic facial
pain clinic). However, TMD was a common secondary
diagnosis; previously, it was also observed that TMD was
prevalent in patients with trigeminal neuralgia27; its associa-
tion with other chronic neuropathic pain may involve central
sensitisation, neurogenic inflammation and peripheral acti-
vation of muscles at the trigeminal complex.
Patients who had orofacial pain presented worse quality of
mastication (P < 0.001), higher pain in mandibular movements
(P = 0.015), higher pain during the muscular palpation of the face
(P < 0.001) and neck (P = 0.002) and more masticatory com-
plaints (P = 0.002). Pain itself has probably interfered with the
mandibular activities, and these findings also support the high
frequency of TMD in this sample. Amongst risk factors for TMD,
bruxism was commonly observed, but the groups did not
statistically differ. Bruxing or clenching the teeth causes an
overload on the masticatory muscles and can precipitate TMD.38
Limitations of this study are the design, which does not
allow the investigation of cause–effect associations, and a
higher frequency of women in the study group. Chronic pain is
more frequent in the female gender,24 and it might haveinterfered with the results observed. Doses of antidepressants
and anti-hypertensive drugs, which were not investigated,
may also have underlain, at least in part, the results as to lower
salivary flow in the study group.
In conclusion, orofacial pain patients need to be evaluated
in regard to their salivary function. They had lower salivary
flow and more xerostomia complaints than the controls,
which can cause discomfort and effectively contribute to
pain.
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